A Study of Orelabrutinib in Patients With ITP

Clinical trial NCT05124028 · UNKNOWN

Trial details

NCT number: NCT05124028
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2021-12-01
Primary completion: 2022-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.